Status not kept up to date
Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy
NCT05926635 · MarsiBionics · Updated 27 Sept 2024
- What is being tested
- ATLAS 2030
- For
- Cerebral Palsy
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 3 years to 14 years. About 60 people. The full rules are on the registry page.
- Where
- Spain (5 sites)
- When
- Starts or started 3 Aug 2023, ends 11 May 2025. Registered 3 July 2023.
- Results
- None posted yet.
In the researchers' words
Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.
Sites
- Hospital Universitario Gregorio MarañónMadrid, Spain
- Hospital Infantil Universitario Niño Jesús-Servicio de RehabilitaciónMadrid, Spain
- Hospital Universitario Niño Jesús-Servicio de Neuro OrtopediaMadrid, Spain
- Hospital Universitario 12 de OctubreMadrid, Spain
- Hospital Universitario La PazMadrid, Spain